Wound Closure Products Market to Surpass $10,148.7 Million Revenue in 2030: P&S Intelligence

22 Nov 2022
NEW YORK, Nov. 22, 2022 /PRNewswire/ -- According to the recent market research study published by P&S Intelligence, the
wound closure products market has garnered $6,540.1 million revenue in 2021. Moreover, it is projected to advance at a rate of 5.0%, to generate $10,148.7 million revenue in 2030. It is ascribed to technological advancements, increasing elderly population, rising incidence of diabetes, and surging healthcare expenditure.
In addition, the rising volume of surgical procedures, led by the increasing prevalence of chronic diseases, and the growing count of road accidents propel the industry size.
Homecare Settings To Witness Fastest Growth
Homecare settings will experience the fastest growth in the coming years, at a rate of 6%. It will be due to the worldwide increasing elderly population, rising adoption of home healthcare services, and growing usage of easy-to-use products.
Moreover, patients with accident wounds and diabetic foot ulcers need to be hospitalized for a long duration. It is usually difficult and costly and, thus, results in a high requirement for wound closure products in homecare settings.
Get the sample pages of this report:
https://www.psmarketresearch.com/market-analysis/wound-closure-products-market/report-sample
Hospitals and Clinics Hold Largest Revenue Share
Hospitals and clinics have captured the largest industry share, and they are expected to retain the same position in the near future. It is led by the enhancing hospital infrastructure, availability of advanced products, greater patient footfall in these settings, and their increasing accessibility to populations of varying income levels.
Rising Surgery Volume Boosts Demand for Wound Closure Equipment
The worldwide rising number of surgeries and increasing usage of wound closure products propel the industry. The major factors contributing to the increasing volume of surgical procedures are the rising count of road accidents and growing prevalence of diabetes, cancer, and necrotizing fasciitis. These conditions result in nasty wounds, which are hard to heal and need proper care for a longer period.
The rising number of burn cases and growing incidence of injuries in low-and middle-income countries also propel the number of surgeries and, thus, boost the wound closure product demand. In addition, many chronic diseases need surgeries at some point, which boosts the demand for these products.
Sutures Dominate Industry
Sutures capture the largest industry share, around 35%, and they are projected to retain their dominance throughout this decade. It is driven by the rising usage of sutures to bring together damaged tissue, after cuts, surgery, lacerations, injury, and road accidents, worldwide rising prevalence of surgical procedures, and suturing material advancements.
Browse detailed report on
Wound Closure Products Market Size, Share, Trends and Growth Analysis 2022-2030
Surgical Staples To Witness Fastest Growth
Surgical staples are projected to experience the fastest growth in consumption, ascribed to their massive usage to speed up the healing of surgical wounds and linear lacerations.
In addition, the rising popularity of stapling is led by their ease of usage and consistency compared to suturing. The easy availability of advanced staplers with single as well as multiple usage options also results in their surging popularity in bariatric surgeries, arthroplasties, bowel surgeries, cholecystectomies, and Cesarean sections.
North America Captures Largest Industry Share
North America holds the largest industry share, around 40%, and it is projected to follow the same trend in the coming years. It is ascribed to the rising prevalence of chronic diseases, including diabetes, and the increasing incidence of sports injuries and road accidents.
Global Wound Closure Products Market
Report Coverage
By Product Type
Non-absorbable
Staples
Adhesives & Tissue Sealants
Synthetic
Non-synthetic
Collagen-based
Strips
Mechanical Wound Closure Devices
Hemostatic Agents
By Wound Type
Surgical & Traumatic Wounds
Burns
By End User
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Asia-Pacific
China
India
Japan
South Korea
Australia
Latin America
Brazil
Mexico
Middle East and Africa
Saudi Arabia
South Africa
Browse More Reports Published by P&S
Global HIV Diagnosis Market Size, Share, Growth and Demand Forecast to 2030
Global Advanced Visualization Market Size, Share, Growth and Demand Forecast to 2030
Global eClinical Solutions Market Size, Share, Growth and Demand Forecast to 2030
Global Wearable Injectors Market Size, Share, Growth and Demand Forecast to 2030
About
P&S Intelligence
P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.
Contact:
Prajneesh Kumar
P&S Intelligence
Phone: +1-347-960-6455
Email: [email protected]
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter
Logo: https://mma.prnewswire.com/media/1224988/P_and_S_Intelligence_Logo.jpg
SOURCE P&S Intelligence
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.